FDA Brief

Warning letters Food

FDA warning letter to

Fresh Nutrition Inc

MediumIssued May 27, 2021Posted Jun 22, 2021Office of Human and Animal Food Operations –West Division 5

FDA warned Fresh Nutrition Inc that its website and Amazon listings made drug claims for eight supplements, one sold for dogs.

What happened

FDA reviewed the company's website (fresh-nutrition.com) in March and May 2021 and also reviewed its Amazon storefront. FDA found claims that the products treat, prevent or cure conditions such as cold and flu, arthritis, high blood pressure, anxiety and depression, which FDA says makes them unapproved new drugs. FDA also found the Green Lipped Mussels product promoted for joint pain and arthritis in dogs, making it an unapproved new animal drug. There was no facility inspection.

What FDA found

  1. The website and Amazon pages say the products diagnose, cure, treat or prevent disease, which makes them drugs that FDA has not approved.

    Section 201(g)(1)(B) of the Act [21 U.S.C. 321(g)(1)(B)]; sections 301(d) and 505(a) [21 U.S.C. 331(d), 355(a)]
  2. The products are meant for diseases a person cannot safely diagnose or treat alone, so no adequate directions for use can be written for a layperson, making them misbranded.

    Section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]; 21 CFR 201.5
  3. Green Lipped Mussels is promoted for joint pain and arthritis in dogs, so it is a new animal drug with no approved application, making it unsafe and adulterated.

    Sections 201(v), 512(a) and 501(a)(5) of the Act [21 U.S.C. 321(v), 360b(a), 351(a)(5)]

What FDA wants

FDA tells the company to correct the violations promptly and to write back within fifteen working days with the specific steps taken, plus documentation showing how repeat violations will be prevented. If corrections cannot be finished in that time, the company must explain the delay and give a completion date.

Who should pay attention

  • supplement brands that describe their products as treating or preventing disease
  • companies selling supplements through Amazon listings and their own websites
  • firms selling joint or pet supplements that mention disease relief

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk